Claude Leduc
AeroLeads people directory · profile

Claude Leduc Email & Phone Number

Co-Founder - Shareholder at RNA Technologies and Therapeutics
Location: Montreal, Quebec, Canada 16 work roles 1 school
1 work email found @videotron.ca LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email l****@videotron.ca
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Co-Founder - Shareholder
Location
Montreal, Quebec, Canada
Company size

Who is Claude Leduc? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Claude Leduc is listed as Co-Founder - Shareholder at RNA Technologies and Therapeutics, a with 10 employees, based in Montreal, Quebec, Canada. AeroLeads shows a work email signal at videotron.ca and a matched LinkedIn profile for Claude Leduc.

Claude Leduc previously worked as Co-Founder - President, Chief Executive Officer at Rna Technologies & Therapeutics Inc. and Executive Chairman at Inception Therapeutics Inc.. Claude Leduc studied at University Of Montreal.

Company email context

Email format at RNA Technologies and Therapeutics

This section adds company-level context without repeating Claude Leduc's masked contact details.

*@videotron.ca
68% confidence

AeroLeads found 1 current-domain work email signal for Claude Leduc. Compare company email patterns before reaching out.

Profile bio

About Claude Leduc

I am a Pharma/Biotech/Medical Device professional Executive CEO / COO with 37 years of international experience and achievement in private and Fortune 500 Companies.Qualities attributed to me are exemplary leadership; ability to set clear goals and oversee their effective execution, and directing/coaching/inspiring teams and individuals to shine.An organization that is strategically committed to producing substantial, sustainable growth for all stakeholders can benefit from the professional and personal equity that I will invest.Specialties: Senior Management / Business Development / Marketing / Sales Regenerative Technologies, Proteomics, orthopaedics, Rheumatology, Cartilage Repair, wound healing, Pain Management, OB/Gyn, Dermatology, etc..

Listed skills include Commercialization, Medical Devices, Biotechnology, Pharmaceutical Industry, and 16 others.

Current workplace

Claude Leduc's current company

Company context helps verify the profile and gives searchers a useful next step.

RNA Technologies and Therapeutics
Rna Technologies And Therapeutics
Co-Founder - Shareholder
Montreal, QC, CA
Employees
10
AeroLeads page
16 roles · 41 years

Claude Leduc work experience

A career timeline built from the work history available for this profile.

Co-Founder - President, Chief Executive Officer

Rna Technologies & Therapeutics Inc.

Montreal, Quebec, Canada

RNA Technologies and Therapeutics Inc. (RNA T&T) is a privately held company headquartered in Montreal, Canada, that specializes in the design, optimization and small-mid scale production (mg to g) of RNA including nucleoside modified messenger RNA, RNA formulation and the development of mRNA-based technologies/therapeutics. We are committed to address infrastructural barrier to clinical and translational research in vaccine development, gene therapy, stem cell reprograming, and other non-viral gene therapy-based applications by providing high quality in vitro transcribed RNA (e.g., mRNA, lncRNA, and circRNA) and targeted lipid-based (LNPs) and hybrid delivery systems, or nanoparticles, to the biotech industry, and academic partners. Our business model, current research and development efforts, and therapeutic pipeline aim to develop innovative mRNA-based therapeutics/technologies that will improve the health and wellbeing of individuals around the world.

Executive Chairman

Inception Therapeutics Inc.

Montreal, Quebec, Canada

Company Vision - Understanding the Molecular Genetics’ inception of diseases leads to novel therapeutic diagnostics and cures.Mission Statement - Creating early diagnostic tools and developing novel therapeutic solutions for targeted chronic disabling diseases in pediatric and adult populationsActual Projects - Developing both an early Osteoarthritis therapeutic small molecule and diagnostic test, to stop and potentially reverse the OA pathogenesis process in early diagnosed OA population.

Aug 2013 - May 2022

President & Ceo

Montreal, Canada

Ortho Regenerative Technologies Inc. is an orthopedic biotechnology company developing novel therapeutic tissue repair devices to dramatically improve the success rate of Sports Medicine Surgerieswww.orthorti.com

Jun 2019 - Apr 2022

President & Ceo

Victoria, British Columbia, Canada

Proteomics Biomarkers Assays, analytical services and clinical DiagnosticsMission:Providing the broader PHARMA / BIOTECH scientific community with tools and technologies to facilitate proteomics research and translating proteomics research into advanced diagnostics for clinical world wide market opportunities, that will benefit patients

Sep 2016 - Dec 2018

Bio-Pharma/Medical Device/ Professional Executive

Leduc Healthcare Consulting

Montreal, Canada

Feb 2011 - Aug 2016

President - Coo - Board Director

Axcelon Dermacare Inc.

Toronto, Ontario, Canada

Axcelon Dermacare Inc. is a majority owned subsidiary of Axcelon Biopolymers Corp. based in Toronto, Ontario, and focusing on developing advanced wouncare products and technologies.Axcelon Dermacare lead product is NanodermTM, a unique woundcare product indicated for a variety of acute wound treatments including burns and dermabrasions as well as for chronic wounds such as venous leg ulcers, pressure ulcers and diabetic foot ulcers. Nanoderm™ has unique Health economic advantages over other competitive wound dressings with a one-time application dressing in most wound types. The product additionally provides a suitable barrier to infections while allowing gaseous exchange, some exudate evaporation and pain alleviation.Axcelon has furthermore developed Nanoderm™Ag; a patented biopolymer wound care dressing with slow release silver for infected wounds. Nanoderm™Ag is planned to be launched in 2017.

Dec 2014 - May 2016

President - Coo - Board Director

Axcelon Biopolymers Corp.

London, Ontario

Axcelon Biopolymers Corporation is an innovative biomaterials company focused on leveraging its unique Bacterial Nanocellulose (BNC) platform technology to develop high value products for wound care, medical devices, tissue engineering, and industrial applications.

Jun 2014 - May 2016

Axcelon Biopolymers Corp.

Senior Advisor - Board Director

London, Ontario, Canada

Helping, guiding and supporting the CEO with corporate vision, development and organization.

May 2012 - Jun 2014

Senior Advisor, Global Marketing & Sales

Piramal Healthcare Inc.

Montreal, Canada

International Commercialization Plan and implementation.Commercialization options and recommendation.Marketing and sales strategies.Partnering search and alliances.

Jul 2011 - Dec 2012

President & Ceo

Biosyntech Canada Inc

Established in 1995 and traded on the TSX Venture since 2004, BioSyntech has created and developed innovative biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery, which appeal unmet medical needs.• Financing – IPO and private investments of over $45 million over 4 years• Clinical – Built a team and structure to execute Canadian and International clinical trials (Canada, Europe and Korea) for two products (cartilage repair & wound healing) and with two others in the pipeline• Operations – Built the teams, structures and physical plant to meet manufacturing needs, and QA/QC regulatory requirements for the clinical trial programs and the early commercialization phase• Obtained ISO-9001 and ISO 13485 certifications• Business Development – Secured commercial partnerships in Asia and managed negotiations with worldwide partners and prepared the company to its pre-commercialization phase

2003 - 2008 ~5 yrs

Director International Markets

Greater Boston Area

Genzyme BioSurgery liaison for international marketing distributorsLead all aspects of development for the international orthopaedic business including:• International marketing and sales strategies and plans in existing and new markets: evaluation, creation and execution• Managing existing and creating new market distribution partnerships• Establishing new corporate offices and direct marketing & sales organizations in South East Asia, including Australia, Malaysia, Singapore • Scientific and clinical training with distributors and their local medical communities• Preparation and presentation of scientific and clinical lectures on viscosupplementation to orthopaedic surgeons, and rheumatologists in Canada, France, Sweden, Greece, England, Singapore, Malaysia, Thailand, Hong Kong, India, LATAM, the Middle East and others• Training of physicians to become speakers in Canada, Europe, and Asia• Training of Corporate marketing and sales force staff in USA, Europe, LATAM, and Canada

2001 - 2004 ~3 yrs

Director Canadian Business Unit / European Markets Development

• Reclaimed the business from International Pharma licensee to start a new Genzyme/Biomatrix (merger) Canadian marketing and sales team in Canada• Achieved remarkable results trending from -35% in 1999 to + 45% in 2001• Developed new European markets• Marketing and sales liaison between Headquarters and European partners• Delivered Scientific, clinical and marketing viscosupplementation courses for medical, marketing and sales; including staff and partners in Europe as well as in Central and South America

1993 - Jun 2001

Regional Manager

Serono Labs

• Developed infertility clinics in the Province of Quebec• Trained medical staff on gonadotrophins usage for in vitro-fertilization• Developed patient education programs in partnership with local clinics and created media kits to enhance awareness

1992 - 1993 ~1 yr

Senior Sales Representative

Syntex Labs

• Pharma products promotion in Quebec hospitals• Sales promotion in Cardiology, Rheumatology, Orthopaedic surgery, Dermatology, Anesthesia, Ob/Gyn, etc.• Won National Sales Awards 1988, Best in Canada

1986 - 1991 ~5 yrs
1 education record

Claude Leduc education

FAQ

Frequently asked questions about Claude Leduc

Quick answers generated from the profile data available on this page.

What company does Claude Leduc work for?

Claude Leduc works for RNA Technologies and Therapeutics.

What is Claude Leduc's role at RNA Technologies and Therapeutics?

Claude Leduc is listed as Co-Founder - Shareholder at RNA Technologies and Therapeutics.

What is Claude Leduc's email address?

AeroLeads has found 1 work email signal at @videotron.ca for Claude Leduc at RNA Technologies and Therapeutics.

Where is Claude Leduc based?

Claude Leduc is based in Montreal, Quebec, Canada while working with RNA Technologies and Therapeutics.

What companies has Claude Leduc worked for?

Claude Leduc has worked for Rna Technologies And Therapeutics, Rna Technologies & Therapeutics Inc., Inception Therapeutics Inc., Ortho Regenerative Technologies, and Mrm Proteomics Inc..

How can I contact Claude Leduc?

You can use AeroLeads to view verified contact signals for Claude Leduc at RNA Technologies and Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Claude Leduc attend?

Claude Leduc studied at University Of Montreal.

What skills is Claude Leduc known for?

Claude Leduc is listed with skills including Commercialization, Medical Devices, Biotechnology, Pharmaceutical Industry, Orthopedic, Business Development, Cardiology, and Clinical Research.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Claude Leduc you were looking for.

View similar profiles